Ysios Capital — Full Portfolio

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

Craig Palmer(Executive Officer)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)

BoardGeoff Pardo(Director)

Co-investorsNew Enterprise Associates (NEA)Treo Ventures, LlcWindham Capital PartnersHatteras Venture PartnersVensana Capital

BiotechArlington, US

Justin Hanes(Director)Kevin Pojasek(Executive Officer)Darius Kharabi(Executive Officer)Todd Bazemore(Executive Officer)Mark Iwicki(Executive Officer, Director)Mary Reumuth(Executive Officer)

Co-investorsLongitude CapitalSR One Capital ManagementAtlas VentureLux CapitalThird Rock Ventures

Mineralys Therapeutics is a clinical-stage pharmaceutical company developing lorundrostat, a treatment targeting dysregulated aldosterone.

BiotechHealthtechRadnor, US

Eric Warren(Chief Commercial Officer)Alex Gold(Chief Medical Officer)Adam Levy(Executive Officer)Alexander Asam(Director)

BoardBrian Taylor Slingsby(Founder & former CEO / Board Director)Olivier Litzka(Director)in

Co-investorsAndera PartnersSamsara BioCapitalSR One Capital ManagementBoulder VenturesCatalys PacificRA Capital

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.

BiotechDigital HealthMedical DevicesSan Diego, US

Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)Vikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)

Co-investorsForesite CapitalLongwood FundNorwest Venture PartnersRiverVest Venture Partnersabrdn plcEight Roads Ventures+4 more

Kynexis is a clinical-stage biotech developing KYN-5356, an oral small-molecule KAT-II inhibitor targeting the kynurenine pathway to improve cognition in neurological diseases.

BiotechDeep TechHealthtech

Robert Schwarcz(Scientific Co-founder)Carol Tamminga(Scientific Co-founder & Chair of the SAB)Christer Köhler(Founding Director)Kees Been(Chief Executive Officer)inJens Wendland(Chief Medical Officer)inNeil Swami(Chief Business Officer)

Co-investorsForbionNovartis Venture FundSunstone Capital

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesAsabys PartnersCriteria Bio VenturesNew Enterprise Associates (NEA)+2 more

Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis.

BiotechHealthtechParis, FR

Co-investorsHealthCapKurma PartnersNovartis Venture FundRoche Venture FundColumbus Venture PartnersEurazeo+1 more

Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs.

BiotechDigital HealthMedical Devices

Co-investorsVida VenturesJeito Capital

AELIX Therapeutics is a company developing a therapeutic HIV vaccine intended for use in HIV cure and eradication strategies.

BiotechHealthtechBarcelona, ES

Co-investorsCriteria Bio Ventures

AM-Pharma develops ilofotase alfa, a recombinant alkaline phosphatase enzyme therapy, and is studying it as a treatment for adults with hypophosphatasia (HPP), a rare inherited metabolic bone disease.

BiotechHealthtech

Co-investorsAndera PartnersKurma Partners

Anaconda Biomed develops neurovascular medical devices, including the ANA funnel-based aspiration catheter, for endovascular treatment of acute ischemic stroke from large vessel occlusion, such as mechanical thrombectomy.

HardwareHealthtechMedical DevicesBarcelona, ES

Co-investorsAsabys PartnersEuropean Investment BankInnogest Capital

Babyscripts provides a maternity care platform with remote patient monitoring, risk screening, and care management services for pregnant and postpartum patients.

Digital HealthFemTechHealthtech

Co-investorsCU Healthcare Innovation FundMemorialCare Innovation FundPhilips VenturesBuilders + BackersCivilization Ventures Management, LlcIrishAngels+4 more

Babyscripts offers a maternity care platform with remote patient monitoring, risk screening, and care management services for prenatal and postpartum patients.

Digital HealthFemTechHealthtech

Co-investorsAAF Management Ltd.IrishAngels

Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses.

BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US

George B. Rathmann(First CEO)

BoardWilliam K. Bowes

Co-investorsAsset Management CompanyBOMCWRU Technology VenturesMayfield FundUS Venture Partners

Ipsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document.

BiotechHealthtech

Co-investorsNew Enterprise Associates (NEA)

CorWave is a medical device company developing heart-assist pumps designed as a physiological solution for patients with heart failure.

Deep TechHealthtechMedical Devices

Co-investorsSofinnova Partners

Cytoki Pharma is a clinical-stage biotechnology company developing IL-22-based medicines for metabolic diseases such as obesity and type 2 diabetes, and conditions involving epithelial injury like inflammatory bowel disease.

BiotechHealthtechVærløse, DK

Rasmus Jorgensen(Founder)

Co-investors+ND CapitalSeventure Partners

Abbott's cardiovascular division provides cardiac and vascular medical devices and technologies, including electrophysiology products for treating conditions such as AFib and remote hemodynamic monitoring for heart failure.

HealthtechMedical Devices

Co-investorsAndera Partners

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.

BiotechHealthtech

Co-investorsFACIT (Fight Against Cancer Innovation Trust)HealthCapLumira VenturesSeroba Life SciencesVenture OntarioAdams Street Partners+2 more

Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.

BiotechMedical Devices

Jennifer Jarrett(Chief Executive Officer & Board Director)Sherwin Sattarzadeh(Chief Operating Officer)Becker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)Jim Baker(Chief Corporate Affairs Officer)Brian Burkavage(Senior Vice President, Finance)

Co-investorsEIR VenturesHadean VenturesM VenturesSEED Capital DenmarkSunstone CapitalMaverick Ventures+1 more

Inbiomotion develops the MAF Test, a biomarker diagnostic based on MAF gene expression that helps doctors select early breast cancer patients for adjuvant bisphosphonate treatment.

BiotechDigital HealthMedical Devices

Co-investorsCriteria Bio VenturesAlta Life SciencesAsabys Partners

The National Kidney Foundation is a nonprofit organization focused on kidney disease, providing patient education, emotional support, and resources for patients, families, living donors, and transplant recipients.

HealthtechImpact & Social Good

Co-investorsBioGeneration VenturesEpidarex CapitalRoche Venture FundScottish National Investment BankSofinnova Partners

LAVA develops the Gammabody® platform, a cancer therapy technology that generates bispecific antibodies to activate gamma-delta T cells for targeted tumor recognition and immune response activation.

BiotechHealthtechMedical Devices

Steve Hurly(Chief Executive Officer)Ton AdangOxana Polyakova(Chief Scientific Officer)Hans van der Vliet(Head of Innovation)

Co-investorsMRL Ventures FundSanofi Ventures

Co-investorsAndera PartnersKurma PartnersSeroba Life SciencesVI Partners

Memo Therapeutics AG is a late-stage biotech company developing therapeutic antibodies for patients with viral infections and cancer.

BiotechMedical Devices

Co-investorsAdjuvant CapitalFresenius Medical Care VenturesKurma PartnersPureos BioventuresVerve Venturesredalpine

Minoryx is a biopharmaceutical company that discovers and develops drug treatments for severe orphan diseases of the central nervous system, such as cerebral adrenoleukodystrophy and Rett syndrome.

BiotechHealthtech

Co-investorsChiesi VenturesCriteria Bio VenturesFund+Invivo Capital PartnersKurma PartnersRoche Venture Fund+1 more

ClinicalTrials.gov is a public registry and results database of clinical studies conducted around the world, maintained by the U.S.

Digital HealthHealthtech

Co-investorsAdvent Life Sciences

Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders.

BiotechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Executive Officer)Arnold Kriegstein(Director)

BoardPeter Svennilson(Director)inTim Kutzkey(Director)Ray Kelleher(Director)

Co-investorsBerkeley FrontierIaso VenturesThe Column GroupAlexandriaFidelity InvestmentsLYFE Capital+7 more

NorthSea Therapeutics is a late-stage clinical biotechnology company developing structurally engineered fatty acids (SEFAs) as oral treatments for metabolic, cholestatic, and fibrotic diseases.

BiotechHealthtech

Co-investorsNew Science VenturesvenBio PartnersSofinnova Ventures

Ona Therapeutics is a biotechnology company developing first-in-class antibody drug conjugates (ADCs) and antibody therapies targeting the molecular biology of treatment-refractory advanced cancers.

BiotechHealthtech

Co-investorsFund+KorysMérieux Equity PartnersAlta Life SciencesAsabys PartnersBpifrance+2 more

OxThera is a privately-held biopharmaceutical company developing Oxabact, an orally administered enteric biotherapy that promotes secretion and degradation of oxalate in the gut to reduce kidney burden.

BiotechHealthtechMedical DevicesStockholm, SE

Co-investorsSunstone Capital

Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.

BiotechHealthtechMedical DevicesCopenhagen, DK

Co-investorsCardinal PartnersM VenturesSeroba Life SciencesSunstone Capital

ReproNovo is a biopharmaceutical company developing therapies for fertility and women's health, targeting male infertility (low testosterone/sperm production), female fertility (embryo implantation and IVF/ICSI success), and adenomyosis.

BiotechFemTechHealthtech

Co-investorsJeito CapitalM Ventures

CSL is a biotechnology company that develops and manufactures plasma-derived and other therapies, including biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and kidney disease.

BiotechHealthtechMedical Devices

Joan Perello Bestard(Founder)inCris Calsadain

Co-investorsAndera PartnersCriteria Bio VenturesInvivo Capital Partners

SparingVision is a genomic medicine company developing gene therapies for ophthalmic diseases, including SPVN06, a neuroprotective gene therapy for retinal conditions.

BiotechDeep TechDigital Health

Co-investorsAdBio partnersJeito Capital

QIAGEN provides sample preparation and molecular testing technologies, including automated DNA/RNA extraction, digital PCR, and syndromic testing systems.

BiotechHealthtechMedical Devices

Co-investorsHarmonic Growth PartnersPfizer Venture Investments

Synendos Therapeutics is a clinical-stage neuroscience company developing therapies that target the Endocannabinoid System to treat neuropsychiatric disorders at their root cause.

BiotechDeep TechMental Health

Co-investorsKurma PartnersSunstone Capital

Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target.

BiotechHealthtechMedical DevicesNijmegen, NL

Co-investorsBifLightstone VenturesNew Enterprise Associates (NEA)Novartis Venture FundGilde HealthcareOost NL

Takeda is a global pharmaceutical company that develops medicines and treatments for patients, focused on advancing science, technology, and partnerships to create new standards of care.

BiotechHealthtechTokyo, JP

Claudia D'Augusta(Executive Officer)Eduardo Bravo Fernandez de Araoz(Executive Officer, Director)Marie Paule Richard(Executive Officer)Wilfried Dalemans(Executive Officer)

BoardJune Almenoff(Director)Russell Greig(Director)

Co-investorsKleiner PerkinsRho VenturesKreos Capital

VarmX is developing VMX-C001, a universal bypassing agent designed to restore blood coagulation in patients taking Factor Xa Direct Oral Anticoagulants (FXa-DOACs).

BiotechMedical Devices

Co-investorsSound BioventuresUNIIQBGVBioGeneration VenturesEICEQT Life Sciences+2 more

Xeltis is a medtech company developing bioresorbable vascular implants, such as its aXess conduit for hemodialysis access, that are gradually replaced by the patient's own living tissue.

BiotechHealthtechMedical Devices

Eliane Schutte(CEO)

Co-investorsKurma PartnersVI PartnersEQT Life SciencesInvest-NL